BMS-986158

N/A

Report date: 2026/05/09 20:00:18
NME

Base Information

Drug NameBMS-986158
Drug Alias NameBET inhibitor - BMSBMS-986158
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBromodomain and extra terminal domain protein inhibitors
TargetsBromodomain and extra terminal domain protein
Therapy Area/IndicationsSolid tumoursPrimary MyelofibrosisBrain Neoplasms +[6
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesPoland +[14
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsSolid tumoursPrimary MyelofibrosisBrain Neoplasms +[5
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A